HYDE JOSEPH R III 13D and 13G filings for Oncternal Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-12-18 4:05 pm Purchase |
2020-12-18 | 13D | Oncternal Therapeutics, Inc. ONCT |
HYDE JOSEPH R III | 73,407 2.990% |
1,904 (+2.66%) |
Filing |